Oxana Beskrovnaya, Ph.D.Chief Innovation Officer at Dyne TherapeuticsSpeaker
Agenda Sessions
Targeted Delivery of Oligonucleotides for Neuromuscular Diseases: From Research to Functional Improvement in the Clinic
, 2:00pmView Session